Wessely thinks blinding will be a problem in a rituximab trial, I dont think he has ever mentioned this as a problem in the PACE trial. In fact it isn't as much of an issue issue for rituximab as for PACE as they plan to infuse saline so the patients, at least, will not be aware of what they get. Don't know enough about rituximab to know if those administering the solutions can tell the difference. As I know this I'm sure Wessely does - and is just trying to undermine the rituximab trial. Dont think he's ever mentioned blinding as a problem for PACE or accepted any of the other well documented problems. I'm afraid in the UK those prbems, despite being well documented, are still largely ignored by the medicl establishment and the press.
You've paraphrased some of his comments so its not possible to point out the areas where he has been evasive or economical with the truth.
If Rituximab is ever approved by NICE - and he will do his best to ensure it isn't - he would have to prescribe it or, more likely, to refer patients to other doctors to prescribe it. Once a physical treatment is approved he, as a psychiatrist, should ony be treating patients with ME if they also had psychiatric illness and that was the major concern.
Proper investigation and treatment of patients with ME is expensive. In the uk labelling it as a psychiatric problem means patients are denied proper testing. Its supposed to be a diagnosis of exclusion but many peope dont even get the few recommended tests. Hence you get things like undiagnosed coeliac disease. When you do get a decent ME service (like Newcastle) 40% are found to have treatable problems. I quote "(40%) of patients seen by the Newcastle Service could in fact be diagnosed with other conditions. The most common alternative diagnosis in these patients was fatigue associated with a chronic disease (47% of all alternative diagnoses). The next common alternative diagnosis was primary sleep disorder (20%), including 8 patients with obstructive sleep apnoea and 12 with another primary sleep disorder – an important finding since sleep disorders form a significant and potentially treatable diagnostic group. Furthermore, 15% of all alternative diagnoses were psychological/psychiatric illnesses (most commonly, depression, anxiety and post-traumatic stress disorder); 13% were “unexplained” but not ME/CFS (5.2% of total referrals); and 4% were cardiovascular disorders (vasovagal syncope in patients with fatigue symptoms, who also had a history of episodes of loss of consciousness"
You've paraphrased some of his comments so its not possible to point out the areas where he has been evasive or economical with the truth.
If Rituximab is ever approved by NICE - and he will do his best to ensure it isn't - he would have to prescribe it or, more likely, to refer patients to other doctors to prescribe it. Once a physical treatment is approved he, as a psychiatrist, should ony be treating patients with ME if they also had psychiatric illness and that was the major concern.
Proper investigation and treatment of patients with ME is expensive. In the uk labelling it as a psychiatric problem means patients are denied proper testing. Its supposed to be a diagnosis of exclusion but many peope dont even get the few recommended tests. Hence you get things like undiagnosed coeliac disease. When you do get a decent ME service (like Newcastle) 40% are found to have treatable problems. I quote "(40%) of patients seen by the Newcastle Service could in fact be diagnosed with other conditions. The most common alternative diagnosis in these patients was fatigue associated with a chronic disease (47% of all alternative diagnoses). The next common alternative diagnosis was primary sleep disorder (20%), including 8 patients with obstructive sleep apnoea and 12 with another primary sleep disorder – an important finding since sleep disorders form a significant and potentially treatable diagnostic group. Furthermore, 15% of all alternative diagnoses were psychological/psychiatric illnesses (most commonly, depression, anxiety and post-traumatic stress disorder); 13% were “unexplained” but not ME/CFS (5.2% of total referrals); and 4% were cardiovascular disorders (vasovagal syncope in patients with fatigue symptoms, who also had a history of episodes of loss of consciousness"